Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Am J Dermatopathol ; 41(9): 637-643, 2019 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-30908293

RESUMEN

In our routine and consultative pathology practices, we have noticed that a relatively high proportion of spindle cell predominant trichodiscomas demonstrate a remarkable stromal admixture of adipose tissue, which along with spindle cells, prominent collagen bundles and myxoid change closely resembles spindle cell lipoma (SCL). To clarify their possible relationship to SCL, 25 cases of trichodiscoma and fibrofolliculoma with stromal "lipomatous metaplasia" were collected and examined using immunohistochemical stains [CD34 and retinoblastoma-1 (RB1) protein] and fluorescence in situ hybridization (RB1 deletion). The patients ranged in age from 35 to 81 years (median 64 years). The male to female ratio was almost equal (14:11). All tumors with a known location were situated on the face with a special predilection for the nose. All cases were sporadic, with all patients having a single lesion and showing no clinical features of Birt-Hogg-Dubé syndrome. No case with available follow-up presented with a recurrence or an otherwise aggressive clinical course. Spindle cell stroma was immunohistochemically positive for CD34 in 16 of 20 cases, and 18 of 19 cases showed loss of RB1 staining in lesional spindle cells. Fluorescence in situ hybridization analysis detected RB1 gene heterozygous deletion in 6 of 20 cases. We conclude that despite the SCL-like appearance of the investigated cases, the majority of them supposedly represent genuine spindle cell predominant trichodiscomas with adipose tissue admixture. However, there was a subset of histopathologically indistinguishable cases with proved RB1 deletion, which likely represent SCL with trichodiscoma/fibrofolliculoma-like epithelial/adnexal induction rather than spindle cell predominant variant of trichodiscoma.


Asunto(s)
Eliminación de Gen , Lipoma/genética , Lipoma/patología , Nevo de Células Fusiformes/genética , Neoplasias Cutáneas/genética , Neoplasias Cutáneas/patología , Adulto , Factores de Edad , Anciano , Anciano de 80 o más Años , Biopsia con Aguja , Bases de Datos Factuales , Diagnóstico Diferencial , Femenino , Heterocigoto , Humanos , Inmunohistoquímica , Hibridación Fluorescente in Situ , Masculino , Persona de Mediana Edad , Nevo de Células Fusiformes/patología , Estudios Retrospectivos , Medición de Riesgo , Factores Sexuales , Células del Estroma/patología
2.
Am J Surg Pathol ; 42(8): 1042-1051, 2018 08.
Artículo en Inglés | MEDLINE | ID: mdl-29794873

RESUMEN

Recent molecular studies of spitzoid neoplasms have identified mutually exclusive kinase fusions involving ROS1, ALK, RET, BRAF, NTRK1, MET, and NTRK3 as early initiating genomic events. Pigmented spindle cell nevus (PSCN) of Reed is a morphologic variant of Spitz and may be very diagnostically challenging, having histologic features concerning for melanoma. Their occurrence in younger patients, lack of association to sun exposure, and rapid early growth phase similar to Spitz nevi suggest fusions may also play a significant role in these lesions. However, to date, there is little data in the literature focused on the molecular characterization of PSCN of Reed with next-generation sequencing. We analyzed a total of 129 melanocytic neoplasms with RNA sequencing including 67 spitzoid neoplasms (10 Spitz nevi, 44 atypical Spitz tumors, 13 spitzoid melanomas) and 23 PSCN of Reed. Although only 2 of 67 (3.0%) of spitzoid lesions had NTRK3 fusions, 13 of 23 (57%) of PSCN of Reed harbored NTRK3 fusions with 5' partners ETV6 (12p13) in 2 cases and MYO5A (15q21) in 11 cases. NTRK3 fusions were confirmed with a fluorescent in situ hybridization break-apart probe. The presence of a NTRK3 fusion correlated with younger age (P=0.021) and adnexal extension (P=0.001). Other minor fusions identified in PSCN of Reed included MYO5A-MERTK (2), MYO5A-ROS1, MYO5A-RET, and ETV6-PITX3 leading to a total of 78% with fusions. Our study suggests that the majority of PSCN of Reed are the result of genomic fusions, and the most frequent and characteristic genomic aberration is an NTRK3 fusion.


Asunto(s)
Biomarcadores de Tumor/genética , Receptor con Dominio Discoidina 2/genética , Fusión Génica , Nevo de Células Fusiformes/genética , Neoplasias Cutáneas/genética , Adolescente , Adulto , Niño , Preescolar , Femenino , Predisposición Genética a la Enfermedad , Secuenciación de Nucleótidos de Alto Rendimiento , Humanos , Hibridación Fluorescente in Situ , Masculino , Persona de Mediana Edad , Nevo de Células Fusiformes/patología , Fenotipo , Neoplasias Cutáneas/patología
3.
Cancer Genomics Proteomics ; 15(3): 193-200, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29695401

RESUMEN

BACKGROUND: Spindle cell/pleomorphic lipomas are benign tumors. Here, we present our cytogenetic data on 31 such tumors. MATERIALS AND METHODS: G-banding chromosome analysis and (in selected cases) fluorescence in situ hybridization (FISH) using probes for FOXO1, RB1, and HMGA2 were performed. RESULTS: Rearrangements of chromosome 13 were found in 58% of tumors. Chromosomes 6, 1, 12, and 11 were also involved in 42%, 26%, 26%, and 23% of tumors, respectively. FISH analysis showed heterozygous deletion of RB1 in seven samples with chromosome 13 aberrations. In four of them, FOXO1 was also deleted. In two tumors with 12q15 rearrangements, FISH confirmed that HMGA2 was targeted. CONCLUSION: Structural rearrangements of 13q or losses of an entire chromosome 13 are the most common cytogenetic aberrations in spindle cell/pleomorphic lipomas. However, cytogenetic variation exists similarly to what is found in other lipomas, suggesting that various pathways may be responsible for tumorigenesis.


Asunto(s)
Cromosomas Humanos Par 13/genética , Hibridación Fluorescente in Situ/métodos , Cariotipificación/métodos , Lipoma/genética , Proteínas de Neoplasias/genética , Nevo de Células Fusiformes/genética , Adulto , Anciano , Anciano de 80 o más Años , Aberraciones Cromosómicas , Bandeo Cromosómico , Análisis Citogenético , Femenino , Proteína Forkhead Box O1/genética , Proteína HMGA2/genética , Humanos , Lipoma/patología , Masculino , Persona de Mediana Edad , Nevo de Células Fusiformes/patología , Proteínas de Unión a Retinoblastoma/genética , Ubiquitina-Proteína Ligasas/genética
4.
Am J Surg Pathol ; 42(5): 595-603, 2018 05.
Artículo en Inglés | MEDLINE | ID: mdl-29635259

RESUMEN

Melanocytic tumors rarely display extensive dermal myxoid deposits except in the myxoid variant of melanoma. We describe in 4 patients the unusual association of morphologic and genetic features. All cases occurred in males and were located on the limbs or proximal girdle area. Age at diagnosis ranged from 8 to 47 years. Size ranged from 6 to 11 mm. Microscopic analysis showed compound, but mainly dermal melanocytic nevi, all presenting a deep dermal expansion with fascicules of amelanotic spindled cells floating in a myxoid background. Cytologic atypia and mitotic activity were low. The superficial portion was either of spitzoid or nevoid cytology with a limited junctional component. In the initial case, the dermal myxoid component was predominant with rare, barely visible, superficial melanocytic nests. This peculiar morphology was responsible for a delayed diagnostic, which required an extensive panel of antibodies ruling out most, potentially myxoid, soft tissue tumors. We later observed the presence of similar, but more limited, dermal morphologic features in 3 other cases. Immunohistochemistry in the deep myxoid areas was melanA, ALK, SOX10, and MiTF. Molecular studies confirmed the ALK rearrangement by an ALK break-apart fluorescence in situ hybridization technique and by RNA sequencing. The latter identified 4 different 5'-fusion partners. Two gene fusions were undescribed: FBXO28(e2)-ALK(e19) and NPAS2(e2)-ALK(e19), and 2 previously described: TPM3(e7)-ALK(e20) and PPFIBP1(e9)-ALK(e19). No relapse or metastatic evolution was seen during follow-up (3 to 24 mo). We denominated this potentially challenging new variant of compound nevus linked to a kinase fusion: Melanocytic Myxoid Spindle Cell Tumor with ALK Rearrangement.


Asunto(s)
Quinasa de Linfoma Anaplásico/genética , Biomarcadores de Tumor/genética , Reordenamiento Génico , Melanocitos , Nevo de Células Fusiformes/genética , Neoplasias Cutáneas/genética , Adolescente , Adulto , Niño , Diagnóstico Diferencial , Fusión Génica , Predisposición Genética a la Enfermedad , Humanos , Inmunohistoquímica , Hibridación Fluorescente in Situ , Masculino , Melanocitos/enzimología , Melanocitos/patología , Persona de Mediana Edad , Nevo de Células Fusiformes/enzimología , Nevo de Células Fusiformes/patología , Nevo de Células Fusiformes/cirugía , Fenotipo , Valor Predictivo de las Pruebas , Neoplasias Cutáneas/enzimología , Neoplasias Cutáneas/patología , Neoplasias Cutáneas/cirugía , Adulto Joven
6.
Rev. esp. enferm. dig ; 108(1): 43-47, ene. 2016. ilus
Artículo en Inglés | IBECS | ID: ibc-148595

RESUMEN

We report a case of a 50-year-old woman who presented to the emergency department with large bowel obstruction and anemia. The initial imaging study suggested an inoperable rectal tumor with involvement of surrounding structures. In this paper, we discuss the diagnostic work-up of this patient with a diagnosis of pelvic/ perirectal inflammatory myofibroblastic tumor (IMT). IMT is a rare tumor with intermediate malignant potential that frequently mimics clinical and imaging features of malignancy. Additionally, to the best of our knowledge, this is the first case of a pelvic IMT that regressed without surgical excision (AU)


No disponible


Asunto(s)
Humanos , Femenino , Adulto , Neoplasias del Recto/metabolismo , Neoplasias del Recto/patología , Obstrucción Intestinal/complicaciones , Obstrucción Intestinal/patología , Anemia/sangre , Ultrasonografía/métodos , Nevo de Células Fusiformes/genética , Neoplasias del Recto/tratamiento farmacológico , Neoplasias del Recto/cirugía , Obstrucción Intestinal/metabolismo , Obstrucción Intestinal/terapia , Anemia/metabolismo , Ultrasonografía/instrumentación , Nevo de Células Fusiformes/metabolismo
7.
Arkh Patol ; 77(4): 17-23, 2015.
Artículo en Ruso | MEDLINE | ID: mdl-26485776

RESUMEN

OBJECTIVE: to comparatively study the immunohistochemical profile and to analyze mutations in the BRAF and N-RAS genes. MATERIAL AND METHODS: The spindle cell melanomas taken from the Institute's archives were divided into 6 groups according to the results of clinical and morphological analyses and follow-up studies. Immunohistochemical examination was conducted in 58 cases, including 19 nodular spindle cell melanomas, 10 superficial spreading melanomas, 4 combined melanomas, 8 sarcoma- toid melanomas, 13 mixed desmoplastic melanomas, and 4 pure desmoplastic melanomas. RESULTS: All tumors of the spectrum in question expressed S100, SOX10, KBA.62, nestin, and cyclin D1. The rate of positive staining was 80% for MITF, 69% for PNL2, 61% for HMB45, 58% for Melan A, 36% for CD117, and 35% for SMA. The expression of HMB45 and Melan A was diffuse and marked in the groups of nodular and superficial spreading melanomas; sarcomatoid and mixed desmoplastic melanomas showed only scattered stained cells; pure desmoplastic melanomas were negative to these markers. SMA immunoexpression was observed in only sarcomatoid and desmoplastic types. Dual S100 staining showed a separate actin-positive myofibroblast-like population disappearing in more cellular zones. EMA, claudin 1, and DOG1 were negative in all cases. BRAFV expression was detected in 14% (in 2 nodular and 1 superficial spreading melanomas) and correlated with the presence of mutation. NRAS mutation was found in 1 nodular spindle cell melanoma. Desmoplastic melanomas did not harbor the above mutations. CONCLUSION: This study indicates the variant heterogeneity of spindle cell melanomas, as confirmed by clinical, morphological, immunohistochemical, and molecular examinations. The findings may be useful in the differential diagnosis of these tumors.


Asunto(s)
Melanoma/genética , Melanoma/patología , Nevo de Células Fusiformes/genética , Nevo de Células Fusiformes/patología , Diagnóstico Diferencial , GTP Fosfohidrolasas/genética , Humanos , Inmunohistoquímica , Melanoma/clasificación , Melanoma/metabolismo , Proteínas de la Membrana/genética , Mutación , Nevo de Células Fusiformes/clasificación , Nevo de Células Fusiformes/metabolismo , Proteínas Proto-Oncogénicas B-raf/genética
8.
Acta Derm Venereol ; 92(2): 152-5, 2012 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-22169934

RESUMEN

Congenital melanocytic naevi can give rise to secondary melanocytic tumours, such as proliferative nodules and malignant melanoma. The clinical and histological features of both lesions may be nearly identical, which makes an unequivocal diagnosis impossible. In particular, it is difficult to differentiate clearly between benign and malignant proliferation in infants with secondary melanocytic proliferation. Reports on melanocytic proliferation and malignant melanoma within the paediatric age-group are very rare. There is limited expert knowledge on this subject and little is known about prognosis and outcome. We report here a case of an infant with an unusual transformation of a congenital spindle cell naevus of the umbilical region, and discuss clinical, histological and genomic criteria.


Asunto(s)
Melanoma/diagnóstico , Nevo de Células Fusiformes/patología , Neoplasias Cutáneas/patología , Diagnóstico Diferencial , Femenino , Humanos , Lactante , Recién Nacido , Antígeno Ki-67/metabolismo , Antígeno MART-1/metabolismo , Antígenos Específicos del Melanoma/metabolismo , Nevo de Células Fusiformes/congénito , Nevo de Células Fusiformes/genética , Proteínas S100/metabolismo , Neoplasias Cutáneas/congénito , Neoplasias Cutáneas/genética , Antígeno gp100 del Melanoma
9.
Am J Surg Pathol ; 35(11): 1733-42, 2011 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-21997694

RESUMEN

Pigmented spindle cell nevus (PSCN), also known as Reed nevus, is a distinctive melanocytic tumor that can show worrisome clinical and histologic features mimicking a malignant melanoma. From a series of 46 pigmented spindle cell melanocytic lesions, including 22 PSCN and 24 spindle cell malignant melanomas (SCMMs), we collected clinical and histopathologic characteristics and evaluated cell cycle and apoptosis regulators by immunohistochemistry. Moreover, fluorescence in situ hybridization (FISH) using probes targeting 6p25 (RREB1), 11q13 (CCND1), 6q23 (MYB), and centromere 6 was performed. PSCN presented in younger people, frequently in women, and were small lesions under 7 mm in diameter affecting the lower limbs, whereas SCMMs arose more frequently in the trunk, upper limbs, and head and neck region. Histologically, symmetry, good lateral demarcation, and uniformity of cellular nests were significantly differential features of PSCN, whereas pagetoid and adnexal spread were frequently seen in both tumors. Immunohistochemical markers that significantly differed from melanomas were Ki-67, cyclin D1, and survivin. FISH was positive in 1 of 15 PSCN and was negative in 4 of 15 SCMMs. These results correlated to a sensitivity of 73% and a specificity of 93%. In conclusion, in the evaluation of pigmented spindle cell melanocytic tumors, the integration of clinical and histologic assessment is essential. However, ancillary techniques such as proliferation antigen Ki-67, cyclin D1, survivin, and FISH can be useful as adjunctive tools.


Asunto(s)
Inmunohistoquímica , Hibridación Fluorescente in Situ , Melanoma/diagnóstico , Nevo de Células Fusiformes/diagnóstico , Neoplasias Cutáneas/diagnóstico , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Apoptosis , Proteínas Reguladoras de la Apoptosis/análisis , Proteínas Reguladoras de la Apoptosis/genética , Biomarcadores de Tumor/análisis , Biomarcadores de Tumor/genética , Biopsia , Proteínas de Ciclo Celular/análisis , Proteínas de Ciclo Celular/genética , Proliferación Celular , Distribución de Chi-Cuadrado , Niño , Preescolar , Diagnóstico Diferencial , Femenino , Humanos , Masculino , Melanoma/química , Melanoma/genética , Melanoma/patología , Persona de Mediana Edad , Nevo de Células Fusiformes/química , Nevo de Células Fusiformes/genética , Nevo de Células Fusiformes/patología , Valor Predictivo de las Pruebas , Sensibilidad y Especificidad , Neoplasias Cutáneas/química , Neoplasias Cutáneas/genética , Neoplasias Cutáneas/patología , España , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA